4processed
Form 4 — Insider Transaction
Lexeo Therapeutics, Inc.(LXEO)
Filing Date
June 29, 2026
Accepted
June 29, 2026
Accession No.
0002083206-26-000005
CIK
0001907108
Insider Transactions
| Insider | Title | Type | Shares | Price | Value | Owned After | Security | Date |
|---|---|---|---|---|---|---|---|---|
| Tamayo Louis Edward | Chief Financial Officer | Other | 12.0K | $0 | — | 101.7K | Common Stock | Jun 29, 2026 |
| Tamayo Louis Edward | Chief Financial Officer | Other | 4.6K | $4.49 | — | 97.0K | Common Stock | Jul 1, 2026 |